{
    "organizations": [],
    "uuid": "050f64c4596a2fa65d95b4537bf76deeaf122a6f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-health-canada-approves-rituxan-sub/brief-health-canada-approves-rituxan-subcutaneous-formulation-for-canadians-with-chronic-lymphocytic-leukemia-idUSFWN1R40PJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Health Canada Approves Rituxan Subcutaneous Formulation For Canadians With Chronic Lymphocytic Leukemia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 12:18 PM / Updated 13 minutes ago BRIEF-Health Canada Approves Rituxan Subcutaneous Formulation For Canadians With Chronic Lymphocytic Leukemia Reuters Staff March 22 (Reuters) - Roche Holding AG: * HEALTH CANADA APPROVES RITUXAN® SUBCUTANEOUS FORMULATION FOR CANADIANS WITH CHRONIC LYMPHOCYTIC LEUKEMIA * ‍HOFFMANN-LA ROCHE - HEALTH CANADA APPROVES RITUXAN SC FORMULATION FOR CANADIANS WITH CHRONIC LYMPHOCYTIC LEUKEMIA​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-22T14:18:00.000+02:00",
    "crawled": "2018-03-22T14:34:13.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "canada",
        "approves",
        "rituxan",
        "subcutaneous",
        "formulation",
        "canadian",
        "chronic",
        "lymphocytic",
        "leukemia",
        "reuters",
        "staff",
        "march",
        "reuters",
        "roche",
        "holding",
        "ag",
        "health",
        "canada",
        "approves",
        "subcutaneous",
        "formulation",
        "canadian",
        "chronic",
        "lymphocytic",
        "leukemia",
        "roche",
        "health",
        "canada",
        "approves",
        "rituxan",
        "sc",
        "formulation",
        "canadian",
        "chronic",
        "lymphocytic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}